EXEL
Exelixis (EXEL)
NASDAQ
$58.40+$0.46 (+0.79%)
Price as of Oct 02, 2026 4:42 PM EDT
  • $14.4B
    Market Cap
  • 40.12%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 76
Valuation
EXEL
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 61
Valuation
EXEL
vs History
vs S&P 500
3-Month Momentum
4.56%
12-Month Momentum
38.08%
3-Month Risk Adjusted Momentum
29.12%
12-Month Risk Adjusted Momentum
105.63%

True Yield

N/A
Valuation
EXEL
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
7.70%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
EXEL
vs History
vs S&P 500
Ohlson's O-Score
12